LYNX1 CAPITAL MANAGEMENT LP purchased 27.8% of their position (128.85K shares) of PASSAGE BIO, INC. on the open market
Open‑market purchase worth $733.8K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/24/2025ACC: 0000902664-25-003152
10% Owner
Since Aug 2024
+128.85K
Net shares
Net buyer
$733.8K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
128.85K acquired
Non-Derivative Transactions3
Common stock, $0.0001 par value per share ("Common Stock")
Indirect
Shares
+13.12K
Price / share
$5.44
Trade value
$71.34K
% of position
2.8%
7/22/2025
462.85K→475.97K
Common Stock
Indirect
Shares
+49.30K
Price / share
$5.74
Trade value
$283.03K
% of position
10.4%
7/23/2025
475.97K→525.27K
Common Stock
Indirect
Shares
+66.42K
Price / share
$5.71
Trade value
$379.45K
% of position
12.6%
7/24/2025
525.27K→591.70K
Total
Net shares
+128.85K
Net value
$733.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value per share ("Common Stock") Indirect | 7/22/2025 | P · Purchase | +13.12K | $5.44 | $71.34K | 2.8% | 462.85K | 475.97K |
| Common Stock Indirect | 7/23/2025 | P · Purchase | +49.30K | $5.74 | $283.03K | 10.4% | 475.97K | 525.27K |
| Common Stock Indirect | 7/24/2025 | P · Purchase | +66.42K | $5.71 | $379.45K | 12.6% | 525.27K | 591.70K |
| Total | +128.85K | $733.83K | ||||||
Derivative Transactions0
No derivative transactions reported